Key information of the specs for the Boson SARS-CoV-2 antigen self-tests that we distribute in Europe. For test kits in single-pack, we can offer the following terms from our OTG stock in Tananger, Norway: Product SARS-CoV-2 Rapid antigen test card (nasal) Brand Boson Biotech Pcs/box 250 tests Pcs/ctn 1 test Catalogue no. 1N40C5-2 Quantity 50'000 - 600000 tests Price/test EURO 0,61
Our newly-developed monkeypox antigen rapid test kit by our R &D department is CE certificate
COV19/ FluA/ FluB Antigen Combo Rapid Test Kit (Colloidal Gold Method) Packing Specifications The kit is an in vitro immunochromatographic assay for the qualitative detection of Cov19, Influenza A and Influenza B virus antigens in human nasopharyngeal, oropharyngeal swab, and salvia samples. Cov19 is an acute respiratory infectious disease that humans are easily infected with. According to current epidemiological investigations, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main symptoms are: fever, fatigue, dry cough, in a few cases can appear nasal congestion, sore throat, myalgia and diarrhea. Influenza, often called the flu is caused by the influenza virus. It is a highly contagious viral infection of the respiratory tract that can be spread by coughing or sneezing. Influenza outbreaks occur every fall and winter. There are influenza A, B and C viruses. Influenza A viruses are more prevalent than influenza B and Cand causes more severe illness. Cov19 infection and Influenza virus infection have similar symptoms, such as fever, cough, etc. This kit can simultaneously detect the antigens of the three viruses and provides an easy workflow, short turnaround time, and rapid diagnosis of Cov19, Influenza A and influenza B virus infections using nasopharyngeal, oropharyngeal swab or salvia samples. The kit is an immunochromatographic assay,based on double antibody sandwich method to detect Cov19 and Influenza A/B virus antigens. This method does not require expensive medical instruments and consumables. After adding the extracted specimen to the sample well on the test cassette, Cov19, Influenza A/B virus antigens in the sample will interact with the colloidal gold-labeled anti-CoV-2 and Influenza A/B antibodies on the conjugate pads. Then the conjugate pad will release re-solubilized conjugate onto the nitrocellulose membrane. The nitrocellulose membrane (NC membrane) diffuses it forward. As the sample moves along the device binding reagents situated on the nitrocellulose membrane bind to the target at the test line. If the sample contains a COV19 antigen, it will bind to the colloidal goldanti-CoV-2 Np monoclonal antibody, diffuse forward, and then react with the anti-CoV-2 Np monoclonal antibody immobilized on the NC membrane detection line (COV19 Test line). Similarly, if the specimen contains Influenza A/Influenza B antigens, the antigens will react with antibody-coated particles, the conjugate migrate laterally forward, and cause a colored lines (A, B linesrespectively).
Product Name Neutrophil Gelatinase-Associated Lipid Carrier Protein (NGAL)Test Kit (Immunofluorescence Chromatography) Purpose To detect the NGAL in human plasma/serum/whole blood in vitro quantitatively.For Professional Use only. Principles of Detection The NGAL Test is a fluorescent lateral flow immunoassay. The test consists of: 1) a conjugate pad containing NGAL antibody conjugated with fluorescent microspheres and a control antibody (goat anti-chicken IgY antibody) conjugated with fluorescence microspheres, 2) a nitrocellulose membrane strip containing a test line (T line) and a control line (C line). The T line is pre-coated with anotherNGAL antibody, and the C line is pre-coated with a control line antibody (chicken IgY antibody). NGAL concentration in specimen is positively correlated with the fluorescent density of the microspheres, after the measure and calculation of the quantitative fluorescence immunoassay analyzer, then the analyzer would calculate the concentration of NGAL according to the preset calibration curve in the machine and display the result, detection unit is ng/mL. C line should appear in any cases, which indicates the reaction system is effective. Reference range Reference value: 37-180ng/mL; The reference value is verified by referring to similar products on the market. Due to ethnic and regional differences, each laboratory can establish its own reference interval according to the actual situation.
Blood sample size: 1-2 µL; if sample applied at the center of test pad. Sample type: Capillary, Venous, Arterial, Neonatal. Sample dosing: Large test pad for top dosing suitable for AST options. Compatibility: Only with AC Active meter. Storage: +2C to 30C. Quality control: 2 levels - 50 mg/dL and 150 mg/dL. Strip Stability: 18 months
New Sealed in Box FreeStyle Lite 50ct Test Strips Expire 02/2024
New Sealed in Box FreeStyle Lite 100ct Test Strips Expire 02/2024
New Sealed in Box OneTouch Ultra Blue 50ct Test Strips Expiration: 10/2023
Intended Use Novel Coronavirus (2019-nCoV) Real-time RT-PCR Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the 2019-nCoV in oropharyngeal swabs and bronchoalveolar lavage fluid collected form individuals suspected of COVID-19 by their healthcare provider. About SARS-CoV-2 Specific antibodies will be produced within days to weeks as the immune system makes immune defense against the SARS-CoV-2 infection. Total antibody detection is an aid in the diagnosis of patients with suspected SARS-CoV-2 infection in conjunction with clinical symptoms and result of other diagnostic methods. The test result should not be used as the sole basis for diagnosis and exclusion of SARS-CoV-2 infection. Total antibody may not be detected in the first few days of infection. SARS-CoV-2 neutralizing antibody is a protective soluble protein secreted by adaptive immunizing cells after inoculation with SARS-CoV-2 vaccine or infection with SARS-CoV-2. These antibodies can specific bind with virus RNA binding domain (RBD) to block the binding of RBD with angiotensin-converting enzyme 2 (ACE2) on human cells surface, thus prevent the virus or its genetic material into the human cell and virus infection. Benifits of the Kit 1) Room Temperature Transportation 2) Cost-Effective Shipping The shipping is at room temperature, with no need of cold chain shipping. 3) Highly Sensitive, Highly Specific Highly sensitive and highly specific for 2019-nCoV, reliable identification of COVID-19. 4) Environmentally Friendly The kit needs neither bulky packaging nor cold chain shipping. Contents A kit contains: Package specifications: 24 tests/kit, 48 tests/kit 1) 2019-nCoV-PCR Master Mix (Lyophilized Powder): 1 bottle/box 2) 2019-nCoV-PCR Positive Control (Lyophilized Powder):1 bottle/box 3) 2019-nCoV Diluent: 1 bottle/box 4) User Manual Note: Do not mix or interchange different batches of kits.
Application For the detection of eye / nose / stool / rectal secretions or blood pathogens The most convenient and rapid diagnostic tool for canine distemper / canine parvovirus Feature High accuracy for monoclonal antibody capture target Good tools for antibody detection and disease diagnosis Easiest reagent to operate the test Quickly present the result Low testing cost Technical specification Technical Parameters for Rapid Canine Distemper Ag Test Kit Principle: colloidal gold lateral chromatography Test samples: eye / nasal secretions or blood Interpretation of time: 10-15 minutes Sensitivity: 98% Specificity: 97% Shelf life: 24 months Storage temperature: 4-28 Packing: 10 Test/ box Technical Parameters for Rapid Feline Parvovirus Ag Test Kit Principle: colloidal gold lateral chromatography Test samples: rectal / feces Interpretation of time: 10-15 minutes Sensitivity: 99% Specificity: 97% Shelf life: 24 months Storage temperature: 2-30 Packing: 10 Test / box
Globally acclaimed Covid Test kits , the best of brands with CE and other requisite certificates are available at a fantastic price ( PanBio/ Flowflex/ Sd Bio sensor) . Delivery all over the globe in 2/ 5 days vide air cargo. We hold the biggest stocks in India. Pl note , prices are quantum based and fluctuate as per demand and supply.
Helicobacter pylori is a parasitic bacterium in the stomach that lives between the gastric mucosa and mucus. According to the WHO, more than half of the world's population has H. pylori and is the third leading cause of cancer-related deaths. In 1994, the WHO's IARC classified H. Pylori as a Class 1 carcinogen. The incidence of H. pylori in developing countries is the highest worldwide, highlighting the need for highly accurate and manageable testing. By 2025, the H. pylori testing market is expected to be worth 6 billion. Accordingly, SML Genetree has developed a reagent that can diagnose Helico-bacter pylori and Clarithromycin-resistant mutants (A2142G, A2143G) through DNA extracted from human hygienic tissue using Real-time Polymerase Chain Reaction. Since it contains multiple gene regions, Helico-bacter pylori and Clarithromycin-resistant mutations can be detected sensitively, and high reproducibility has been demonstrated through repeated tests by serially diluting various positive samples and standards. In addition, as a result of clinical evaluation on human sanitary inspection tissue by commissioning a large domestic consignment inspection institution, high sensitivity and specificity were confirmed, proving its excellent clinical performance.
HPV is a virus that causes papillomas (benign tumors), and about 200 types have been discovered so far. Some types of HPV are known to be the direct cause of cervical cancer, head and neck cancer, etc. In particular, in the case of cervical cancer, more than 99% of the causes are reported to be caused by HPV. If it is detected early, it is easy to treat, but if it is detected late, the 5-year survival rate is less than 15% even with treatment, so regular check-ups are very important. SML Genetree has developed the world's first Ezplex�® HPV NGS Kit to diagnose HPV using the NGS method. Unlike the existing methods that only detected up to 20 to 40 types and only positive-negative, NGS was introduced to provide positive results for 45 types of HPV (up to 100 types including for export) according to the amount of DNA detected in steps 1 to 3 Semi-quantitative inspection of the level is possible. It has a high level of automation that is close to full automatic. The time has been shortened so that up to 480 people can be analyzed within 16 hours with one analysis, and it is possible to distinguish HPV species that were difficult to distinguish precisely. Unlike the existing sequencing method, the NGS method has been highly evaluated for its potential as a precision medical technology that can dramatically reduce time and cost by analyzing numerous DNAs at high speed. As a result of clinical efficacy evaluation with more than 2500 clinical specimens in large domestic hospitals, it is a product with high sensitivity and specificity compared to existing tests.
Ezplex�® SARS-CoV-2 G Kit, developed by SML Genetree, is a product that has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). This is an in vitro diagnostic test that qualitatively detects the nucleic acids of SARS-CoV-2 (RdRp and N genes) in sputum to aid in emergency screening for COVID-19. This product can be used for a large amount of screening tests because it can perform a pooling test, unlike the products that the existing domestic companies have approved for emergency use by the FDA. For the combined test, samples are collected in units of 5 people and tested. If positive, individual tests are performed. In the case of a negative test, all tests are performed in a negative way. In particular, since a large number of samples are tested at once, the test is only possible with high sensitivity and specificity compared to existing diagnostic kits. According to the FDA, it was confirmed that 100% agreement was achieved in the result comparison test of individual and collective tests, and it was the 20th in the world and the first Korean company to pass the test. Excellent clinical performance was demonstrated by confirming high sensitivity and specificity through clinical evaluation, and stability was confirmed for 12 months through long-term storage tests. In January 2021, it was officially approved by the Korean Ministry of Food and Drug Safety (MFDS).
Ezplex MTBC/NTM Real-time PCR Kit is an in vitro diagnostic test that simultaneously detects Mycobacterium tuberculosis complex (MTBC) and 20 types of nontuberculous mycobacteria (NTM). Sensitivity : Multiple gene targets for MTBC and NTM. Clinical Performance: Validated clinical performance. Fast Results: Testing can be completed within 2 hours post extraction.
Ezplex Respiratory Pathogens Real-time PCR Kit is an in vitro diagnostic test for the qualitative detection of 19 respiratory viruses and 6 types of pneumonia-causing bacteria through nucleic acids isolated and extracted from human throat swabs using real-time polymerase chain reaction Comprehensive Panel- One test can identify 19 respiratory viruses and 6 bacterial species simultaneously. Sensitivity Detection of all targeted viruses and bacteria with high sensitivity. Convenience Genetree Viewer analysis software available for users to conveniently produce test results. Clinical Performance: Clinical testing confirmed the high sensitivity and specificity. Stability: Shelf life of up to 12 months. Analytical Specificity: Testing of 31 species of microorganisms showed no cross reactivity.
Ezple Respiratory Pathogens Real-time PCR Kit is an in vitro diagnostic test for the qualitative detection of 19 respiratory viruses and 6 types of pneumonia-causing bacteria through nucleic acids isolated and extracted from human throat swabs using real-time polymerase chain reaction.
MTBC/NTM Real-time PCR Kit is an in vitro diagnostic test that simultaneously detects Mycobacterium tuberculosis complex (MTBC) and 20 types of nontuberculous mycobacteria (NTM).
HP-CLA Real-time PCR kit is an in vitro diagnostic test that qualitatively detects helicobacter pylori and Clarithromycin-resistant mutations from human gastric biopsy tissues. Contains multiple gene targets to detect Helicobacter clarismycin-resistant mutations. Genetree Viewer analysis software is provided, allowing users to conveniently check results.
HLA-DRB1 NGS typing Kit is an in vitro diagnostic test that detects and distinguishes allelic genes of HLA-DRB1 in human leukocyte antigens at high resolution using next-generation sequencing. Ezplex's unique amplicon approach simplifies the traditional complex NGS Library construction process and provides dedicated software optimized for HLA typing for easy analysis. The Ezplex�® HLA-DRB1 NGS typing Kit accurately reads the HLA-type Acuracy % (95% Confidence Interval) in DRB1 Locus within a total of 35 hours from DNA extraction to NGS results analysis to help with pre-transplant testing.
